Search

Your search keyword '"Hallberg E."' showing total 391 results

Search Constraints

Start Over You searched for: Author "Hallberg E." Remove constraint Author: "Hallberg E."
391 results on '"Hallberg E."'

Search Results

1. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

Catalog

Books, media, physical & digital resources

9. Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis

10. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (vol 5, 4999, 2014)

11. Gunter Blobel: Pioneer of molecular cell biology (1936-2018)

15. Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation.

16. A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer

17. Evaluation of polygenic risk scores for breast and ovarian cancer risk prediction in BRCA1 and BRCA2 mutation carriers

18. Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers

19. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

20. Evidence that the 5p12 variant rs10941679 confers susceptibility to estrogen receptor positive breast cancer through FGF10 and MRPS30 regulation

21. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

22. BRCA2 polymorphic stop codon K3326X and the risk of breast, prostate, and ovarian cancers

23. RAD51B in familial breast cancer

24. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

25. Genetic variation in the immunosuppression pathway genes and breast cancer susceptibility: a pooled analysis of 42,510 cases and 40,577 controls from the Breast Cancer Association Consortium

26. Common germline polymorphisms\ud associated with breast cancer-specific survival

27. RAD51B in familial breast cancer.

28. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

29. TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

30. PHIP - a novel candidate breast cancer susceptibility locus on 6q14.1

31. TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer

32. PHIP:a novel candidate breast cancer susceptibility locus on 6q14.1

33. Genetic Predisposition to In Situ and Invasive Lobular\ud Carcinoma of the Breast

34. Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors

35. RAD51B in familial breast cancer

36. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

37. Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21

38. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

39. Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation

40. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

41. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

42. RAD51B in Familial Breast Cancer

43. Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2

44. Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs)

45. Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus

46. Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus

47. Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women

48. Heterogeneity of luminal breast cancer characterised by immunohistochemical expression of basal markers